Back to Blog
    Exams, Assessments & Practice Tools

    NAPLEX Therapeutics Practice Questions with Answers

    May 31, 20269 min read49 views
    NAPLEX Therapeutics Practice Questions with Answers

    NAPLEX Therapeutics Practice Questions with Answers

    Mastering NAPLEX Therapeutics requires a deep understanding of clinical guidelines, drug-disease state interactions, and patient-specific factors to ensure safe and effective medication use. Success on the North American Pharmacist Licensure Examination depends on your ability to apply pharmacological principles to real-world patient scenarios. This comprehensive guide provides the essential NAPLEX Therapeutics Practice Questions with Answers you need to sharpen your clinical judgment and excel on exam day.

    Concept Explanation

    Therapeutics is the branch of medicine concerned with the treatment of disease and the action of remedial agents to achieve specific health outcomes. In the context of the NAPLEX Prep, therapeutics encompasses the selection of appropriate drug therapy based on evidence-based guidelines, monitoring for efficacy and toxicity, and adjusting regimens for specific populations such as geriatric, pediatric, or renal-impaired patients. It integrates knowledge from pathophysiology and pharmacology to solve complex clinical problems. Key clinical resources often cited include the American College of Cardiology for cardiovascular guidelines and the American Diabetes Association for metabolic disorders. Understanding these core concepts allows pharmacists to serve as the final check in the medication-use process, ensuring that every prescription is appropriate for the patient's unique clinical profile.

    Solved Examples

    1. Hypertension Management: A 62-year-old African American male with no other comorbidities has a blood pressure of 152/94 mmHg. Which class of medication is preferred for initial therapy?
      1. Identify the patient's demographic and comorbidities. African American patients without chronic kidney disease (CKD) respond better to specific classes.
      2. Refer to JNC 8 or ACC/AHA guidelines. For African American patients, Thiazide-type diuretics or Calcium Channel Blockers (CCBs) are recommended first-line.
      3. Select the answer: Chlorthalidone or Amlodipine would be appropriate choices.
    2. Creatinine Clearance Calculation: Calculate the C r C l CrCl for a 70-year-old female weighing 60 kg with a serum creatinine ( S C r SCr ) of 1.2 mg/dL.
      1. Use the Cockcroft-Gault equation: C r C l = ( 140 βˆ’ age ) Γ— weight in kg 72 Γ— S C r Γ— 0.85  (for females) CrCl = \frac{(140 - \text{age}) \times \text{weight in kg}}{72 \times SCr} \times 0.85 \text{ (for females)}
      2. Substitute the values: C r C l = ( 140 βˆ’ 70 ) Γ— 60 72 Γ— 1.2 Γ— 0.85 CrCl = \frac{(140 - 70) \times 60}{72 \times 1.2} \times 0.85
      3. Calculate the numerator and denominator: 70 Γ— 60 = 4200 70 \times 60 = 4200 ; 72 Γ— 1.2 = 86.4 72 \times 1.2 = 86.4 .
      4. Final calculation: ( 4200 / 86.4 ) Γ— 0.85 = 48.6 Γ— 0.85 = 41.3  mL/min (4200 / 86.4) \times 0.85 = 48.6 \times 0.85 = 41.3 \text{ mL/min} .
    3. Asthma Step-Up Therapy: A patient is currently using a Low-dose Inhaled Corticosteroid (ICS) plus Formoterol as needed but still experiences symptoms 4 days a week. What is the next step according to GINA guidelines?
      1. Assess current control: Symptoms > 2 days/week indicates inadequate control.
      2. Determine current step: The patient is at Step 2 (as-needed low-dose ICS-formoterol).
      3. Step up: Move to Step 3, which is a daily maintenance low-dose ICS-formoterol plus as-needed ICS-formoterol (MART therapy).

    Practice Questions

    1. A 55-year-old male with a history of Heart Failure with Reduced Ejection Fraction (HFrEF) and an EF of 30% is currently taking Lisinopril 20 mg daily, Carvedilol 25 mg twice daily, and Furosemide 40 mg daily. His BP is 138/84 mmHg and HR is 72 bpm. Which medication should be added next to reduce mortality?

    2. A patient presents with a deep vein thrombosis (DVT). The physician decides to start Enoxaparin. If the patient weighs 185 lbs and has a C r C l CrCl of 45 mL/min, what is the appropriate treatment dose?

    3. Which of the following laboratory parameters must be monitored specifically for a patient starting Clozapine therapy due to the risk of severe neutropenia?

    Practice real clinical decision-making.

    Improve therapeutic reasoning with pharmacy patient cases and scenario-based NAPLEX questions.

    Practice Patient Cases

    4. A 68-year-old female with Type 2 Diabetes and established Atherosclerotic Cardiovascular Disease (ASCVD) has an A1c of 8.2% despite taking Metformin 1000 mg twice daily. Which agent should be prioritized for addition?

    5. A patient with a history of sulfa allergy requires treatment for a urinary tract infection. Which of the following medications should be avoided?

    6. A 45-year-old male is diagnosed with community-acquired pneumonia (CAP). He is otherwise healthy with no recent antibiotic use and no comorbidities. According to IDSA guidelines, which is the preferred outpatient treatment?

    7. Calculate the daily dose of elemental iron for a patient prescribed Ferrous Sulfate 325 mg three times daily.

    8. A patient on Warfarin has an INR of 7.5 with no active bleeding. What is the recommended management according to CHEST guidelines?

    9. Which antidepressant is most likely to cause dose-dependent QTc prolongation, requiring a maximum dose of 20 mg in patients over 60 years old?

    10. A patient is being switched from IV Morphine to Oral Hydromorphone. If the patient is receiving 30 mg of IV Morphine per day, calculate the equivalent daily dose of oral Hydromorphone (Assume Morphine 10 mg IV = Hydromorphone 7.5 mg PO).

    Answers & Explanations

    1. Answer: Spironolactone (or an MRA). According to the AHA/ACC Heart Failure Guidelines, Mineralocorticoid Receptor Antagonists (MRAs) are indicated in patients with HFrEF (EF \u2264 35%) who are already on optimal doses of ACEIs/ARBs and beta-blockers to further reduce mortality. For more on this, see our NAPLEX Cardiovascular Pharmacology Practice Questions with Answers.
    2. Answer: 84 mg SC every 12 hours. First, convert weight to kg: 185 / 2.2 = 84.09  kg 185 / 2.2 = 84.09 \text{ kg} . The standard treatment dose for Enoxaparin is 1 mg/kg every 12 hours. Since the C r C l CrCl is > 30 mL/min, no renal adjustment is needed. Rounding to the nearest syringe size gives 84 mg (or 80 mg depending on available stock). You can find similar problems in the NAPLEX Anticoagulant Practice Questions with Answers.
    3. Answer: Absolute Neutrophil Count (ANC). Clozapine has a REMS program requiring baseline and periodic monitoring of ANC to detect agranulocytosis.
    4. Answer: Empagliflozin (or another SGLT2 inhibitor/GLP-1 RA). For patients with T2DM and established ASCVD, the NAPLEX Diabetes Medication Practice Questions with Answers highlight that SGLT2 inhibitors or GLP-1 receptor agonists with proven CV benefit should be used regardless of A1c.
    5. Answer: Sulfamethoxazole/Trimethoprim (Bactrim). This is a sulfonamide antibiotic and is contraindicated in patients with a true sulfa allergy. Check our NAPLEX Antibiotic Practice Questions with Answers for more cross-sensitivity details.
    6. Answer: Amoxicillin 1g TID, Doxycycline, or a Macrolide (if local resistance < 25%). Standard IDSA/ATS guidelines for healthy outpatients prioritize high-dose amoxicillin or doxycycline.
    7. Answer: 195 mg. Ferrous sulfate contains 20% elemental iron. 325  mg Γ— 0.20 = 65  mg 325 \text{ mg} \times 0.20 = 65 \text{ mg} per tablet. 65  mg Γ— 3 = 195  mg 65 \text{ mg} \times 3 = 195 \text{ mg} per day.
    8. Answer: Hold Warfarin and monitor. For an INR between 4.5 and 10 without bleeding, guidelines recommend withholding 1-2 doses of Warfarin and resuming at a lower dose when the INR is therapeutic. Routine Vitamin K is not recommended unless bleeding occurs or the INR is > 10.
    9. Answer: Citalopram. The FDA issued a warning that Citalopram doses above 40 mg (or 20 mg in the elderly) are associated with QTc prolongation.
    10. Answer: 22.5 mg. Using the provided ratio: 10  mg IV Morphine 7.5  mg PO Hydromorphone = 30  mg IV Morphine X  mg PO Hydromorphone \frac{10 \text{ mg IV Morphine}}{7.5 \text{ mg PO Hydromorphone}} = \frac{30 \text{ mg IV Morphine}}{X \text{ mg PO Hydromorphone}} Solving for X: X = ( 30 Γ— 7.5 ) / 10 = 22.5  mg X = (30 \times 7.5) / 10 = 22.5 \text{ mg} . If you find these conversions challenging, use our AI Question Generator for more practice.
    Interactive quizQuestion 1 of 5

    1. Which of the following is a classic side effect of ACE inhibitors like Enalapril?

    Pick an answer to check

    Frequently Asked Questions

    What are the most common therapeutic topics on the NAPLEX?

    The NAPLEX heavily emphasizes cardiovascular health, infectious diseases, diabetes management, and psychiatric disorders. You should also be prepared for questions regarding oncology, anticoagulation, and renal dose adjustments.

    How do I calculate a patient's pediatric dose based on weight?

    Pediatric dosing is typically calculated using the patient's weight in kilograms multiplied by the recommended mg/kg dose. Always double-check that the calculated dose does not exceed the maximum adult dose for that medication.

    Why is the Cockcroft-Gault equation used for drug dosing instead of eGFR?

    The Cockcroft-Gault equation was the primary method used in original drug pharmacokinetic studies to determine renal dosing adjustments. While eGFR is common in clinical practice for staging kidney disease, most FDA-approved labeling still relies on C r C l CrCl calculated via Cockcroft-Gault.

    What is the difference between a side effect and an adverse drug reaction?

    A side effect is a predictable, often unavoidable secondary effect of a drug occurring at therapeutic doses. An adverse drug reaction is a more harmful, unintended, and sometimes unpredictable response to a medication that may require therapy discontinuation.

    How can I stay updated on changing therapeutic guidelines?

    Pharmacists should regularly consult primary resources like the CDC, the FDA, and professional organizations such as ASHP. Utilizing a structured study plan like the AI MasterPlan can also help you organize new information into your review schedule.

    Practice real clinical decision-making.

    Improve therapeutic reasoning with pharmacy patient cases and scenario-based NAPLEX questions.

    Practice Patient Cases

    Start studying smarter β€” free

    Get personalized AI study tools. No credit card.

    Tags

    NAPLEX

    Enjoyed this article?

    Share it with others who might find it helpful.